For the year ending 2025-12-31, PULM had -$5,433K decrease in cash & cash equivalents over the period. -$5,433K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Purchases of property and equipment | 0 |
| Net cash used in investing activities | 0 |
| Depreciation and amortization | 0 |
| Amortization of operating lease right-of-use asset | 0 |
| Loss on disposals | 0 |
| Accounts receivable | 0 |
| Operating lease liability | 0 |
| Deferred revenue | 0 |
| Net loss | -5,162 |
| Stock-based compensation | 25 |
| Prepaid expenses and other current assets | -358 |
| Other long-term assets | -13 |
| Accounts payable | -537 |
| Accrued expenses and other current liabilities | -63 |
| Fair value adjustment of warrants | -67 |
| Net cash used in operating activities | -5,433 |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -5,433 |
| Net decrease in cash, cash equivalents and restricted cash | -5,433 |
| Cash, cash equivalents and restricted cash beginning of period | 9,531 |
| Cash, cash equivalents and restricted cash end of period | 4,098 |
Pulmatrix, Inc. (PULM)
Pulmatrix, Inc. (PULM)